<qa>  What is the name of the PATIENTs that are LOCALLY ADVANCES0121, NEOADJUVANT CARBOPLATIN, PACLITAXEL, AND GEMCITABINE FOLLOWED BY CISPLATIN AND RADIATION THERAPY IN TREATING PATIENTS WITH LOCALLY ADVANCED OR RECURRENT CARCINOMA OF THE UROTHELIUM: 